Brief: Adverum Biotechnologies Inc - Some Prior Financial Statements Should No Longer Be Relied Upon - SEC Filing
31/03/2025 23:32
Adverum Biotechnologies Inc ADVM.O: ADVERUM BIOTECHNOLOGIES INC - SOME PRIOR FINANCIAL STATEMENTS SHOULD NO LONGER BE RELIED UPON - SEC FILING ADVERUM BIOTECHNOLOGIES INC - COMPANY EXPECTS TO REPORT AT LEAST ONE MATERIAL WEAKNESS - SEC FILING ADVERUM BIOTECHNOLOGIES INC - COMPANY EXPECTS CASH TO FUND OPERATIONS INTO SECOND HALF OF 2025 - SEC FILING Source text: [ID:n0001193125-25-068759] Further company coverage: ADVM.O
Recent news on Adverum Biotechnologies
See all newsNASDAQ TRADE HALT CONTINUES REASON NOT AVAILABLE AT 03:58 AM
NASDAQ TRADE HALT TRADING HALTED; FOR INFORMATION REQUESTED BY NASDAQ AT 07:50 PM
Brief: Adverum Reminds Stockholders To Tender Their Shares Into The Offer By Lilly
Brief: Adverum Biotechnologies Inc - Are-Nc Region No. 21 Llc Terminates Certain Lease Agreement With Adverum Biotechnologies - SEC Filing
Eli Lilly bets on eye care with buyout of gene therapy developer Adverum (updated)